Poisoned Trust

The tragic deaths of more than 20 children in Madhya Pradesh and Rajasthan from toxic cough syrups mark yet another painful reminder of the country’s unresolved crisis in pharmaceutical regulation. This is not the first time Indian-made medicines have caused such devastation, and unless systemic reform follows, it will not be the last. The recurring presence of diethylene glycol ~ a chemical used in industrial solvents ~ in medicines meant for children is a scandal that should have been impossible in a country that prides itself on being the “pharmacy of the world.”

Instead, the latest tragedy exposes the fragile foundations of India’s drug safety regime. Factories operating under shockingly unhygienic conditions, staffed by poorly qualified personnel and devoid of basic quality assurance systems, have no place in a nation that exports life-saving drugs across continents. The World Health Organisation’s expression of “deep concern” over India’s regulatory lapses should not be seen as external criticism but as a global alarm urging India to safeguard its credibility and conscience. The failure here is not merely of one company or one negligent doctor.

Advertisement

It is a collective failure of governance and oversight ~ an indictment of a system that continues to rely on outdated inspection methods, fragmented state-level controls, and sporadic enforcement. The arrest of a factory owner or the suspension of a licence may soothe public anger, but such actions rarely address the deeper malaise. Without a transparent, well-resourced, and digitally integrated regulatory framework, the same story will repeat with different names and numbers. India’s pharmaceutical industry has long been a symbol of national pride, enabling affordable access to essential medicines for developing countries. Yet its reputation is increasingly shadowed by scandals involving substandard or contaminated products.

This contradiction cannot be resolved by public relations or ad-hoc crackdowns. It demands structural reform – one that empowers the Central Drugs Standard Control Organisation (CDSCO) with greater autonomy, staffing, and technology to monitor quality from the factory floor to the pharmacy shelf. Beyond regulation, the tragedy also reflects a troubling social norm: the routine over-the-counter use of syrups and antibiotics for children without medical supervision. India’s culture of self-medication ~ driven by convenience, cost, and occasionally misplaced trust in local chemists ~ has made quick relief more valuable than medical prudence. Educating parents and enforcing stricter dispensing norms must, therefore, form part of the public health response.

India’s drug manufacturing base grew rapidly, but its quality control capacity did not evolve at the same pace. The result is a patchwork system vulnerable to both human negligence and commercial greed. The current outrage should be a turning point – an opportunity to rebuild the credibility of Indian pharmaceuticals through uncompromising standards and transparent accountability. Every child who died after consuming contaminated syrup is a reminder that the price of neglect in public health is always paid by the most innocent. It is time to ensure that India’s medicines heal the world without poisoning its own children